GB2218808A - Detecting device - Google Patents
Detecting device Download PDFInfo
- Publication number
- GB2218808A GB2218808A GB8911070A GB8911070A GB2218808A GB 2218808 A GB2218808 A GB 2218808A GB 8911070 A GB8911070 A GB 8911070A GB 8911070 A GB8911070 A GB 8911070A GB 2218808 A GB2218808 A GB 2218808A
- Authority
- GB
- United Kingdom
- Prior art keywords
- entity
- bilayer
- membrane
- protein
- hydrophobic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 claims description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 230000002209 hydrophobic effect Effects 0.000 claims description 23
- 239000000758 substrate Substances 0.000 claims description 18
- 102000005962 receptors Human genes 0.000 claims description 14
- 108020003175 receptors Proteins 0.000 claims description 14
- 239000003599 detergent Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 150000005829 chemical entities Chemical class 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000012528 membrane Substances 0.000 description 40
- 239000010410 layer Substances 0.000 description 35
- 150000002632 lipids Chemical class 0.000 description 19
- 238000000502 dialysis Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 230000003993 interaction Effects 0.000 description 8
- 102000006240 membrane receptors Human genes 0.000 description 7
- 108020004084 membrane receptors Proteins 0.000 description 7
- 239000011324 bead Substances 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- -1 dipalmitoyl phospholipid nitroxide Chemical class 0.000 description 4
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000000588 Interleukin-2 Human genes 0.000 description 3
- 108010002350 Interleukin-2 Proteins 0.000 description 3
- 102000018697 Membrane Proteins Human genes 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 102000004330 Rhodopsin Human genes 0.000 description 3
- 108090000820 Rhodopsin Proteins 0.000 description 3
- 230000005669 field effect Effects 0.000 description 3
- 239000012212 insulator Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- PYJJCSYBSYXGQQ-UHFFFAOYSA-N trichloro(octadecyl)silane Chemical compound CCCCCCCCCCCCCCCCCC[Si](Cl)(Cl)Cl PYJJCSYBSYXGQQ-UHFFFAOYSA-N 0.000 description 3
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 108091008039 hormone receptors Proteins 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 1
- 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108090000590 Neurotransmitter Receptors Proteins 0.000 description 1
- 108050002069 Olfactory receptors Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- PBZHKWVYRQRZQC-UHFFFAOYSA-N [Si+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O Chemical compound [Si+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O PBZHKWVYRQRZQC-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 102000055277 human IL2 Human genes 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 210000004358 rod cell outer segment Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/5432—Liposomes or microcapsules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4145—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Description
t DETECTING DEVICE This invention relates to detecting devices for example
for chemical entities such as.compounds and ions or for physical stimuli.
is Many devices exist which are able to measure a biologically significant entity such as an antigen in a biological fluid. Such devices include immunosensors, enzyme electrodes, electrochemical sensors, biocatalytic membrane electrodes, enzyme electrodes, peizoelectric crystal detectors, chemical sensors, optoelectronic devices, ion-sensitive electrodes, and devices using mass spectrometry and nuclear magnetic resonance. Schramm et al., 1987, "The Commercialization of Biosensors", Medical Device & Diagnostic Industry, Vol. 9, p. 52.
An immunosensor is a device which has a sensor associated with a population of antibodies or antigens that selectively bind the antibody or antigen to be measured. The antibody-antigen complex "cannot be directly measured by physiochemical means" and so a signal generator is required e.g., an antigen-enzyme conjugate. Schramm et al., Id. at 54. The conjugate converts a substrate for the enzyme to an electroactive product which is detected by an electrochemical detector. The amount of analyte present is determined by the detector's response.
McConnell, U.S. Patent 4,490,216, the disclosure of Which is to be regarded as bereby incorporated by reference, describes an elecLroanalytica.1 device having a solid electrically-sensitive layer with a lipid layer non-diffusively bound to it. Also included is a second lipid layer, formed on the 1-pi(k_ayer, having polar hydrophobic head groups posit-ioned at a distance from 22' 18 8 0 B 1 1 the lipid layer. These polar groups form a layer which acts as an electrostatic.layer, the polarity of which can be sensed by the solid electricallysensitive layer. Variations in the polarity of this layer are detected by the solid layer. The polar layer can be modified by binding a member of a ligand-receptor pair to one of the lipids within the layers, e.g., by binding dipalmitoyl phospholipid nitroxide (DPN). Such a modified device is useful for detecting the other member of this binding pair, if such binding results in a change in electrostatic field in the polar layer.
The present work may be seen in part an extension of the recognition that membrane receptor proteins act as is transduction elements which can convert a stimulus, such as contact with a specific molecule, into an electrical or chemical signal to elicit a response from the cell. A stimulus-triggered change in the three- dimensional structure of the receptor protein appears to be a universal step in this process. For example, binding of a chemical at a specific site on the receptor protein causes a change in configuration of the receptor which may change the permeability of the membrane to ions, and thus initiate an electrochemical transduction, or it may expose a site on the inside of the membrane, and thus &I activate an enzymatic process. Such conformational changes can also cause a change in distribution of charged side chains on the protein with respect to the membrane surface, and thus cause changes in the electrical potential at the membrane surface.
We have designed membrane sensors which make use of this property of entities, such as proteins held within membranes. These sensors can detect small movements (e.g., less than about 2 Angstroms) of charge i 1 A t 1 i is -)s occurring within the hydropho4ic portion of the membrane by measuring a local change in the electric field of the membrane. They can detect not only the movement of such charges, but also the dynamics of this movement. other changes, e.g., optical changes, can also be detected by the sensors.
Accordingly, the invention features a device for detecting a first entity including a support on whose surface there is non-diffusively bound a first hydrophobic layer, overlaid by a second hydrophobic layer to form a bilayer. Within the bilayer there is a second entity capable of reacting with the first entity to produce a local change in a detectable property of the bilayer structure.
In preferred embodiments, the first or second hydrophobic layers contain a plurality of molecules having aliphatic chains of at least six carbon atoms; the first entity is a chemical entity; the second entity is a protein (most preferably a membrane receptor protein) which is freely mobile within the bilayer; the detectable property is an electrical property or a physical property such as light; and the first and second entities are capable of reacting to form an affinity complex (e.g., a complex between a receptor protein and the protein or other entity for which it is specific, e.g., growth factors and their membrane-bound receptor proteins, e.g., interleukin-2 and the interleukin-2 receptor on lymphocytes; or neurotransmitters and neuroreceptors; or hormones and. hormone receptors; or an immune complex) in which the first and second entities interact non-covalently.
Our devices described in detail below provide mans for linking the detection capabilities of biological receptors with established signal processing capabilities of - 4 is solid-state microelectronic and optical devices. These bio-mimetic sensing assemblies offer exceptional measuring capabilities provided by the use of membrane receptor proteins, or similar molecules, in an almost natural environment. Thus, the response of these proteins to various stimuli can be measured, and this response related to the concentration of molecules in a solution which are reactive with these proteins. These membranes can also be constructed using a wide rnge of entities, including not only membrane receptor proteins, but also other proteins, e.g., antibodies, antigens, and enzymes, as well as modified polypeptides.
In our devices in which the mobile entity within the bilayer is a protein, the device responds to stimuli that activate or change functional properties of the protein. Because the environment of the membrane mimics the environment in which the protein naturally functions, its maximal sensitivity is poised in the biological range of interest. The protein molecule, maintained in as near a natural environment as possible, retains its conformational dynamics and thus responds to its natural stimuli; i.e., the sensor will detect natural positive and negative stimuli, as well as mimics of these stimuli. The sensors are useful in medical diagnostics, pharmaceut-ica.L screening, chemical warfare and other toxic agent detection, and illegal drug-use surveillance, as well as in research into membrane receptor mechanics. In addition to their ability in detecting chemical entities such as proteins in solution, the devices can also be used to detect light, smells or odours and changes in pH and temperature.
Other features and advantages of the invention will be apparent from the following description of the
1% - 5 preferred embodiments thereof.
11 1 The drawings will first briefly be described.
is Fig. 1 is a diagrammatic representation of a membrane-mimetic assembly; Fig. 2 is a transverse section through an insulated gate field-effect transistor; and
Fig. 3 is a diagrammat.iq view,of dialysis apparatus useful in forming devices in accofrdance with this invention.
Referring to Fig. 1, surface-bound membrane structure 8, designed to detect a first entity, includes support 10 having surface 12 to which first hydrophobic layer 14 is non-diffusively (i.e., covalently) bonded. Second hydrophobic (lipid) layer 16, containing lipid molecules 17 having polar head-groups 18, is bound to layer 14 through hydrophobic interaction. Polar lipid head-groups 18 face outward, away from substrate 10. Incorporated into the bilayer are second entity (e.g., receptor protein) molecules 20, which are freely mobile in the bilayer. Membrane structure 8 is associated with standard auxiliary electronics to provide a detectable signal when the first entity being detected reacts with the second entity in the membrane. Each component will now be described in greater detail.
First Hydrophobic Layer The first hydrophobic layer provides a surface with which polar lipids can interact to form the bilayer structure resembling a natural membrane. This layer is formed by reacting the surface of the substrate with a solution that contains reactive long-chained hydrocarbon compounds capable of forming covalent bonds with the support e.g., octadecyltrichlorosilane, which can react I with hydroxyl groups on the surface of glass, as described in J. Sagiv., 1979, Isr. J. Chem., Vol. 18, p. 46. Other suitable hydrophobic layer- forming solutions are described in McConnell, supra.
Second H)rdrophobic Layer (Lipid Layer) The lipid layer is deposited on the surface simultaneously with the receptor protein, e.g., by a detergent dialysis procedure, described below. The lipid layer is held to the surface, and oriented as described above, by interaction with the first hydrophobic layer. The polar head-groups face outward from the surface,and the individual lipid molecules are free to diffuse in the plane of the membrane. Examples of lipids suitable in this layer are given in McConnell, supra. The lipids in both the first or second hydrophobic layers may be cross-linked or polymerized to reduce diffusion within the layer.
Second Entit The second entity is preferably a protein or protein-like compound, and most preferably a receptor protein. The second entity is restrained within the bilayer structure by its interaction with the hydrophobic interior of the bilayer.
Preferably, the second entity is a protein which is free to move within the bilayer, and free to undergo conformational rearrangements. Two general classes of proteins are associated with biological membranes peripheral proteins which bind to the hydrophilic surface of the membrane, and integral proteins which are inserted into the hydrophobic interior of the membrane. Preferred membrane structures of the invention utilize integral membrane proteins, particularly those having a polypeptide chain which crosses the juncture between the two membrane layers It 11 more than once. These "transmembrane" proteins are of particular importance in biological sensory processes, e.g., the sensing of light via the light-sensitive protein Rhodopsin.
As mentioned above, a primary attribute of our membrane structures is that they provide an environment about the protein closely resembling the natural membrane bilayer, so that the protein is maintained in an environment optimal for membrane protein function.
Auxiliar Electronics Fig. 2 shows the structure of a conventional insulated gate field-effect transistor (IGFET) 30 which can be operationally associated with membrane structure is 8 using known, standard techniques. Briefly, IGFET has a base 32 formed of p-type silicon. This is treated to form n-type silicon in a drain region 34, and a source region 36. Metal contacts for the source and drain regions are applied, followed by an insulator 39, and a metal layer to form a gate electrode 38 on top of the insulator 39.. In such devices the potential applied to gate electrode 38 attracts or repels charge carriers from the silicon surface of the device. By regulating the population of charge carriers at the surface, the gate potential controls the flow of current between source 36 to drain 34. This current flow is a sensitive measure of the potential field at the device's surface.
The device essentially responds to the potential-dependent accumulation or depletion of carriers at the insulated silicon surface.
To measure the charge movements accompanying membrane protein functions, the conventional IGFET structure.of Fig. 2 is modified by replacing metal gate electrode 38 with surface-bound is membrane assembly 8 (Fig. 1). In this system, the membrane acts as the gate area of the IGFET. The device is encapsulated with an appropriate polymer (e.g. epoxy) in a manner which leaves the gate region with surface-bound membrane exposed to the solution containing the analyte. The insulator isolates the rest of the device including the source and drain electrodes. When used in this manner a reference electrode, in the solution being measured, must be added to provide electrical contact with the solution.
The substrate (support) is chosen to respond to some property of the bilipid layer which changes upon interaction with a stimulus. For example, an electronically responding substrate such as a field effect transistor senses charge movements induced by the interaction of the receptor protein with a stimulus; and an optically responding substrate senses changes in the optical properties of the film upon interaction with the stimulus. One such substrate is described in Hafeman et, al., US Patent 4591550, the disclosure of which is to be regarded as liereby incorporated by reference. Others include such substrLtes as optical fibres. The surface of the substrate is generally modified to provide chemically reactive groups nee ed for coupling with the hydrophobic layer of membrane structure B. Suitable substrates are composed of glass, platinum oxide, silicon dioxide, silicon nitrate, or coated silicon, or any other surface which can be derivatized with lonq-changed hydrocarbons. The surface may be planar or non-planar, e.g., beads as well as flat surfaces can be used. Other suitable substrates are described in McConnell, supra. Manufacture
The membrane structures are formed directly onto solid substrate surfaces using a modified detergent dialysis technique. Surfaces with exposed hydroxyl and other reactive groups are modified by reaction with a variety of organosilanes to form the first layer of the bilayer. For example, the substrate is made hydrophobic by linking long-chained fatty acids to surface groups, such as is achieved by reaction with octadecyltrichlorosilane. The second layer of the bilayer is deposited by detergent dialysis with simultaneous incorporation of protein. The protein and outer leaflet of the bilayer are held to the substrate surface through hydrophobic interactions with the covalently attached inner alkyl group leaflet of the bilayer.
In detergent dialysis, the detergent is slowly removed from solubilized lipid/protein/detergent solutions, and the lipids and proteins recombine to form vesicular bilayer structures. If appropriate choices of detergent and other conditions are made, functional membrane vesicles can be formed. The detergent used must be non-denaturing to the protein and it must have a relatively high critical micelle concentration, to facilitate its removal by dialysis. Octyl glucoside and deoxycholate are most preferable. If a suitable hydrophobic surface is present during the dialysis then some of the lipid and protein will be driven to reform with that surface instead of forming free-floating vesicles. Structures created by such techniques have compositions and electrical characteristics consistent with the formation of bilayer membranes on the substrate surfaces.
The photoreceptor protein rhodops - in was incorporated into membrane structures as follows. Retinal rod outer segment disks were isolated by the method of Smith et al., 1982, Meth. Enzymol., Vol. 81, is p. 57, solubilized with the detergent octylglucoside (OG), and placed into chamber "C" of a flow dialysis apparatus, shown in Fig. 3, such that the solubilized membrane solution was in contact with planar support 10, which previously had been alkylated by treatment with octAdecyltrichlorosilane. Dialysis was performed, using a dialysis membrane A, against a linear concentration gradient (shown in Fig. 3) decreasing from 50 mM to 0 mM octylglucoside over 5 hours, followed by dialysis against detergent-free buffer for 18 hours. The amount of lipid and protein in the suspension was in excess of that required to create a monolayer on the surface and thus substantial amounts of vesicles were formed. Planar substrate 10 was freed of these vesicles by dipping it into buffer solutions.
If glass beads, rather than planar surfaces, are coated, they are separated from vesicles by centrifugation in 50% sucrose, which is sufficiently dense to float the vesicles, but not the membrane-coated glass beads.
The resulting substrates have properties which are consistent with the formation of membrane-like structures on the alkylated surfaces The rhodopsincontent on 37 pm diameter glass beads is 145+28 pg rhodopsin retained per gram of beads. This corresponds to one rhodopsin (Rh) molecule per 2600 Angstroms 2 of surface, which is comparable to the 2500 Angstroms 2 to 3600 Angstroms 2 estimated for the natural disk membrane. The lipid content of these beads is calculated as 83+15 mol phosphate (P)/mol Rh. Again this valu.e is very close to that usually reported for the native disk membrane (50 to 100 mol P/mol Rh). These results indicate that these surface-bound structures have the composition expected for a 9 i i 1 - 11 is membrane-mimetic bilayer.
When the above assembly is formed on the oxidized surface of a planar platinum electrode, and the electrical properties determined by cyclic voltammetry, the measured resistance is 10 7 ohm-cm 2, and the capacitance 0.2 - 0.5 uF/cm 2. These results are close to typical values for natural membranes (resistance, 10 3 _ 10 6 ohm-cm 2; and capacitance, 1 uF/cm 2 Use The membrane assemblies can be used to detect any entity which is reactive with the protein or other entity within the bilayer. For example, the protein in the bilayer can be the human interleukin-2 (IL-2) receptor (described, e.g., in Leonard et al., 1982), Nature (Lond.), Vol. 300, pp. 267-69) and the device used to detect or measure IL-2 in biological fluids such as serum to provide information on the immune status of a human patient.
The invention is also applicable to the detection or measurement of entities reactive with any other membrane receptors and transduction elements including visual, olfactory, neurotransmitter, and hormone receptors. The combination of biological with electronic and optical systems provides a new class of sensors whose specificity is determined by choosing an appropriate membrane receptor protein.
Sensors based upon chemically sensitive receptors can be designed to respond to a variety of biologically active compounds including hormones, neurotransmitters, and toxins. These devices respond both to the natural stimulus and to compounds which inhibit interaction between the receptor and the stimulus. Such chemically sensitive devices have widespread applications including toxic agent detection and assay, drug surveillance, medical diagnostics, and pharmaceutial screening.
Other embodiments are feasible.
For example, the membrane structure can be constructed by known techniques such as those of Langmuir-Blodgett, rather than detergent dialysis.
r, g - 13
Claims (13)
- ClaimsA device for detecting a first entity, comprising: a support having a surface, a first hydrophobic layer non- diffusively bound to'said surface, a second hydrophobic layer overlying said first layer to form a bilayer, and a second entity, reactive with said first entity, positioned within said bilayer, said second entity, while within said bilayer, being capable of reacting with said first entity to produce a local change in a detectable property of said bilayer structure.is
- 2. The device of claim 1, wherein said first or said second hydrophobic layer comprises a plurality of molecules having aliphatic chains of at least six carbon atoms.
- 3. The device of claim 1, wherein said first entity is a chemical entity.
- 4. The device of claim 1, wherein said first entity is a physical stimulus.
- 5. The device of claim 1, wherein said second entity is a protein which is freely mobile within said bilayer.
- 6. The device of claim 1, wherein said detectable property is an electrical property.is 14 -
- 7. The device of claim 1, wherein said detectable property is an optical property.
- 8. The device of claim 5, wherein said protein is a receptor protein.
- 9. The device of claim 1, wherein said first and second hydrophobic layers comprise a polymerized or cross-linked region.
- 10. The device of claim 1, wherein said second entity is capable of reacting with said first entity to form an affinity complex in which said first and second entities are bound non-covalently.
- 11, A method for manufacturing the device of claim 1, comprising the steps of:a) forming said first hydrophobic layer on said solid substrate, b) mixing said second entity with a hydrophobic liquid and a detergent to form a liquid mixture, mixture, and c) contacting said substrate with said d) dialysing said mixture to remove said detergent from said mixture.
- 12. For manufacturing the device of Claim 1, a method substantially as hereinbefore described with reference to the accompanying drawings.
- 13. A device for detecting a first entity substantially as hereinbefore described with reference to and as shown in the accompanying drawings.Published 1989 atThe PatentOffice, Stau House, 66/71 High Holborn, London WCIR4TP- Further copies maybe obtainedfrom The Patentoffice. Sales Branch, St Mary Cray, Orpington, Kent BR5 3RD. Printed by Multiplex techniques ltd, St Mazy Cray, Kent, Con. 1/87 1 1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19389488A | 1988-05-13 | 1988-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2218808A true GB2218808A (en) | 1989-11-22 |
GB2218808B GB2218808B (en) | 1992-09-30 |
Family
ID=22715455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8911070A Expired GB2218808B (en) | 1988-05-13 | 1989-05-15 | Biosensors for detecting physical and chemical stimuli |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH0219767A (en) |
DE (1) | DE3915554A1 (en) |
FR (1) | FR2631449B1 (en) |
GB (1) | GB2218808B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993017339A1 (en) * | 1992-02-28 | 1993-09-02 | Thomson-Csf | Molecular sensor |
EP0751392A3 (en) * | 1995-06-28 | 1997-11-19 | Motorola, Inc. | Biosensor or chemical sensor with indicator film |
EP3647779A1 (en) * | 2018-11-05 | 2020-05-06 | Imec VZW | Field-effect transistor-based biosensor comprising electrolyte-screening layer |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5240133A (en) * | 1991-04-15 | 1993-08-31 | James River Paper Company, Inc. | Clamped-wave lid seal structure |
US5160391A (en) * | 1991-04-15 | 1992-11-03 | James River Ii, Inc. | Method for the formation of a clamped wave seal structure |
DE4339584A1 (en) * | 1993-11-20 | 1995-05-24 | Thomas Dr Hertel | Process and assembly for controlled reversible charging of measuring cell with microorganisms |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2193326A (en) * | 1986-07-22 | 1988-02-03 | Natural Environment Res | Lipid coated electrodes |
GB2195450A (en) * | 1986-09-22 | 1988-04-07 | Atomic Energy Authority Uk | Sensor |
EP0274824A1 (en) * | 1986-11-20 | 1988-07-20 | Hans O. Ribi | Novel lipid-protein compositions and articles and methods for their preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4490216A (en) * | 1983-02-03 | 1984-12-25 | Molecular Devices Corporation | Lipid membrane electroanalytical elements and method of analysis therewith |
US4661442A (en) * | 1984-06-20 | 1987-04-28 | Irt Corporation | Producing lipid-protein membranes for chemical detection |
US4661235A (en) * | 1984-08-03 | 1987-04-28 | Krull Ulrich J | Chemo-receptive lipid based membrane transducers |
-
1989
- 1989-05-12 FR FR8906269A patent/FR2631449B1/en not_active Expired - Fee Related
- 1989-05-12 JP JP1120209A patent/JPH0219767A/en active Pending
- 1989-05-12 DE DE19893915554 patent/DE3915554A1/en not_active Withdrawn
- 1989-05-15 GB GB8911070A patent/GB2218808B/en not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2193326A (en) * | 1986-07-22 | 1988-02-03 | Natural Environment Res | Lipid coated electrodes |
GB2195450A (en) * | 1986-09-22 | 1988-04-07 | Atomic Energy Authority Uk | Sensor |
EP0274824A1 (en) * | 1986-11-20 | 1988-07-20 | Hans O. Ribi | Novel lipid-protein compositions and articles and methods for their preparation |
Non-Patent Citations (1)
Title |
---|
Biotechnology(1987)5 pp437-440 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993017339A1 (en) * | 1992-02-28 | 1993-09-02 | Thomson-Csf | Molecular sensor |
FR2688065A1 (en) * | 1992-02-28 | 1993-09-03 | Thomson Csf | MOLECULAR SENSOR. |
EP0751392A3 (en) * | 1995-06-28 | 1997-11-19 | Motorola, Inc. | Biosensor or chemical sensor with indicator film |
EP3647779A1 (en) * | 2018-11-05 | 2020-05-06 | Imec VZW | Field-effect transistor-based biosensor comprising electrolyte-screening layer |
Also Published As
Publication number | Publication date |
---|---|
FR2631449A1 (en) | 1989-11-17 |
JPH0219767A (en) | 1990-01-23 |
DE3915554A1 (en) | 1989-11-16 |
GB2218808B (en) | 1992-09-30 |
FR2631449B1 (en) | 1993-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4920047A (en) | Electrical detection of the immune reaction | |
Nikolelis et al. | Biosensors based on thin lipid films and liposomes | |
US4822566A (en) | Optimized capacitive sensor for chemical analysis and measurement | |
US5192507A (en) | Receptor-based biosensors | |
Bergveld | A critical evaluation of direct electrical protein detection methods | |
US5001048A (en) | Electrical biosensor containing a biological receptor immobilized and stabilized in a protein film | |
US5756355A (en) | Lipid membrane sensors | |
Tien et al. | Supported bilayer lipid membranes as ion and molecular probes | |
Trojanowicz | Miniaturized biochemical sensing devices based on planar bilayer lipid membranes | |
US20090311670A1 (en) | Apparatus and method for measuring concentration of molecules through a barrier | |
GB2218808A (en) | Detecting device | |
Ameur et al. | Impedimetric measurements on polarized functionalized platinum electrodes: application to direct immunosensing | |
Lee et al. | New antibody immobilization method via functional liposome layer for specific protein assays | |
JP2614905B2 (en) | Immunosensor | |
Hianik | Electrostriction and dynamics of solid supported lipid films | |
Godoy et al. | Kinetics study of Bungarus fasciatus venom acetylcholinesterase immobilised on a langmuir–blodgett proteo‐glycolipidic bilayer | |
Kochev et al. | From'bulk'to'interfacial'types of sensors | |
Tien | Bilayer lipid membrane‐based electrochemical biosensors | |
JPH0326345B2 (en) | ||
JP2957625B2 (en) | Optical sensor | |
Suzuki et al. | Department of Environmental Engineering Saitama Institute of Technology 1690 Fusaiji, Okabe, Saitama 369-02, Japan* Department of Chemical Engineering Tokyo Institute of Technology | |
KOCHEV et al. | Aspects of biomembrane based sensors design | |
Suzuki et al. | Immuno-potentiometric sensors with antigen coated membrane | |
Tien et al. | BLM-based biosensors and devices: applications and future prospects | |
Ahl | Naval Research Laboratory, Bio/Molecular Engineering Branch |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19950515 |